MaxQ AI announces Tom Neufelder as CTO

MaxQ AI, the US and Israel based medical diagnostic AI company has announced the appointment of Tom Neufelder as the company’s new Chief Technology Officer (CTO). In this role, Tom will be responsible for driving engineering, product development, architecture, and the technology strategy for MaxQ AI.

Gene Saragnese, CEO of MaxQ AI said, “We are excited to welcome Tom to the company and to have him join the leadership team. As a veteran in the healthcare space, Tom’s global experience in developing products for some of the largest medical imaging companies, including Philips Imaging and GE Healthcare, will serve MaxQ AI well during a pivotal time in our growth and we will fully leverage his expertise for our customers and partners.”

Tom has had over 30 years of technical and engineering experience in leading multi-disciplinary, global product development organizations. The majority of his career has been in the medical device industry with prior experience in the avionics/defense and graphic arts industries.

“I’m excited to have the opportunity to join MaxQ AI, and to continue to make a meaningful impact in healthcare. Throughout my career, I have been passionate about delivering better healthcare and improved outcomes through innovation, and I am looking forward to pioneering and advancing new AI-powered solutions forward alongside our talented leadership team”, added Tom Neufelder

Prior to MaxQ AI, Tom was the Senior Vice President, Innovation Leader at Philips Healthcare with responsibility for leadership of Idea to Market (I2M) function within the Diagnostic Imaging Business Group, which consists of the Magnetic Resonance (MRI), Computed Tomography (CT), Advanced Molecular Imaging, Diagnostic X-Ray and Imaging Components businesses.

Tom also held several other senior leadership roles at Philips, including Vice President, R&D CT/AMI. Before Philips, Tom held senior positions within GE Healthcare, including Vice President, R&D Outpatient Electronic Medical Record (EMR), and Director of Engineering, Invasive Cardiology.